Assessment of health-related quality of life in patients with nontuberculous mycobacterial pulmonary disease: A comprehensive review

• Published in: Respiratory investigation 2024-11, Vol.62 (6), p.1006-1014
• Main Authors: Kawahara, Kazuma, Tabusadani, Mitsuru, Ohta, Ken, Morimoto, Kozo
• Format: Article
• Language: English
• Subjects: Cross-sectional and longitudinal study; Health-related quality of life; Humans; Lung Diseases - microbiology; Mycobacterium Infections, Nontuberculous; Nontuberculous mycobacterial pulmonary disease; Patient Reported Outcome Measures; Patient-reported outcomes; Pharmacological and nonpharmacological treatments; Prognosis; Quality of Life; Recurrence
• ISSN: 2212-5345; 2212-5353; 2212-5353
• DOI: 10.1016/j.resinv.2024.08.009

The global incidence of nontuberculous mycobacterial pulmonary disease (NTM-PD) is increasing. The primary aim of pharmacotherapeutic treatment for NTM-PD is to achieve negative bacterial conversion, but this goal is challenging, especially in cases with poor prognosis factors. Moreover, recurrence frequently occurs following successful treatment. Consequently, patient-reported outcomes (PROs) have attracted an increasing amount of attention due to their potential to elucidate the pathophysiology of NTM-PD. The current review article aimed to describe the current understanding of PROs related to health-related quality of life (HRQoL). HRQoL is influenced by a variety of factors; notably, those factors associated with the prognosis of NTM-PD significantly impair HRQoL. In patients with refractory NTM-PD, HRQoL tends to worsen over time. Assessing HRQoL through PROs involves short-term or long-term evaluation tools, which are selected based on their relevance to the patient's condition and the clinician's goals. Understanding the nuances of PROs can be helpful for delivering empathetic care tailored to patients in even the most complex treatment scenarios.